Onconova Therapeutics Inc. (ONTX) Hits New 1-Year Low at $3.13
Onconova Therapeutics Inc. (NASDAQ:ONTX)’s share price hit a new 52-week low during mid-day trading on Thursday . The company traded as low as $3.13 and last traded at $3.36, with a volume of 64,317 shares traded. The stock had previously closed at $3.27.
Separately, Maxim Group started coverage on Onconova Therapeutics in a report on Thursday. They set a “buy” rating and a $6.00 target price on the stock. One analyst has rated the stock with a hold rating and four have given a buy rating to the company. Onconova Therapeutics has a consensus rating of “Buy” and an average target price of $24.74.
The company has a 50 day moving average price of $4.55 and a 200-day moving average price of $4.88. The firm’s market cap is $9.56 million.
Onconova Therapeutics (NASDAQ:ONTX) last posted its quarterly earnings results on Thursday, May 12th. The biopharmaceutical company reported ($0.27) EPS for the quarter, missing analysts’ consensus estimates of ($0.19) by $0.08. On average, equities research analysts forecast that Onconova Therapeutics Inc. will post ($7.40) EPS for the current year.
Onconova Therapeutics, Inc is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule drug candidates to treat cancer. The Company has created a targeted anti-cancer agents designed to work against specific cellular pathways important to cancer cells. It has three clinical-stage product candidates and many preclinical programs that target kinases, cellular metabolism or cell division.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.